Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity
Status:
Active, not recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
this work aims to investigate the effect of intrathecal administration of Morphine,
Dexmedetomidine or both in combination on cellular immunity and cytokine production in
patients undergoing major abdominal cancer surgeries.